Stoykova Zhivka, Ivanova Liliya, Cvetkova Snejinka, Yordanova Diana
St Marina University Hospital, Varna, Bulgaria.
Medical University of Varna, Varna, Bulgaria.
Folia Med (Plovdiv). 2020 Jun 30;62(2):403-407. doi: 10.3897/folmed.62.e49840.
Cytomegalovirus (CMV) is a worldwide spread herpes virus that establishes a latent infection after the primary infection. It becomes a major problem in immunocompromised patients and in cases of primary or reactivated infection during pregnancy. CMV is the most common congenital infection and is the leading infectious cause of sensoneural deafness and cerebral mental retardation.
Тo raise the attention to the discordance in our knowledge of cCMV infection and the implementation of the knowledge in prac-tice.
CMV-DNA was extracted from saliva and plasma samples according to the protocol of DNA-Sorb-A, Sacace, Biotechnologies, Italy. Polymerase chain reaction (PCR) was performed using a commercial kit based on the Taq-man principle: Quantitative RT-PCR for CMV-DNA detection (Sacace, Biotechnologies, Italy). The linear range of the CMV Real-TM Quant PCR test is 500-10000000 copies/ml, and the reported sensitivity is 400 copies/ml.
The infant was born with clinical manifestations involving development of hepatosplenomegaly, chorioretinitis, anemia, mi-crocephaly and simultaneous dilatation of the brain ventricles. CMV infection was confirmed using modern PCR studies.
This case highlights the need for specific virological/PCR tests to be performed for all children with the least suspected congenital infection, especially when there is an option of a specific treatment.
巨细胞病毒(CMV)是一种在全球范围内传播的疱疹病毒,初次感染后会建立潜伏感染。它在免疫功能低下的患者以及孕期初次感染或再激活感染的情况下成为一个主要问题。CMV是最常见的先天性感染,是感音神经性耳聋和脑智力发育迟缓的主要感染原因。
提高对我们关于先天性CMV感染的认识与实践中知识应用之间不一致性的关注。
根据意大利Sacace生物技术公司DNA-Sorb-A试剂盒的操作流程,从唾液和血浆样本中提取CMV-DNA。使用基于Taq-man原理的商业试剂盒进行聚合酶链反应(PCR):用于CMV-DNA检测的定量逆转录PCR(意大利Sacace生物技术公司)。CMV Real-TM定量PCR检测的线性范围是500-10000000拷贝/毫升,报告的灵敏度是400拷贝/毫升。
该婴儿出生时伴有肝脾肿大、脉络膜视网膜炎、贫血、小头畸形以及脑室同时扩张等临床表现。通过现代PCR研究证实了CMV感染。
该病例突出表明,对于所有怀疑有先天性感染的儿童,尤其是存在特定治疗选择时,都需要进行特异性病毒学/PCR检测。